| Literature DB >> 35250501 |
Stephanie S Desrochers1, Mitchell G Spring1, Katherine M Nautiyal1.
Abstract
Impulsivity generally refers to a deficit in inhibition, with a focus on understanding the neural circuits which constitute the "brake" on actions and gratification. It is likely that increased impulsivity can arise not only from reduced inhibition, but also from a heightened or exaggerated excitatory "drive." For example, an action which has more vigor, or is fueled by either increased incentive salience or a stronger action-outcome association, may be harder to inhibit. From this perspective, this review focuses on impulse control as a competition over behavioral output between an initially learned response-reward outcome association, and a subsequently acquired opposing inhibitory association. Our goal is to present a synthesis of research from humans and animal models that supports this dual-systems approach to understanding the behavioral and neural substrates that contribute to impulsivity, with a focus on the neuromodulatory role of serotonin. We review evidence for the role of serotonin signaling in mediating the balance of the "drive" and "brake" circuits. Additionally, we consider parallels of these competing instrumental systems in impulsivity within classical conditioning processes (e.g., extinction) in order to point us to potential behavioral and neural mechanisms that may modulate the competing instrumental associations. Finally, we consider how the balance of these competing associations might contribute to, or be extracted from, our experimental assessments of impulsivity. A careful understanding of the underlying behavioral and circuit level contributions to impulsivity is important for understanding the pathogenesis of increased impulsivity present in a number of psychiatric disorders. Pathological levels of impulsivity in such disorders are likely subserved by deficits in the balance of motivational and inhibitory processes.Entities:
Keywords: impulsivity; inhibition; learning; reward; serotonin
Year: 2022 PMID: 35250501 PMCID: PMC8892181 DOI: 10.3389/fnbeh.2022.791749
Source DB: PubMed Journal: Front Behav Neurosci ISSN: 1662-5153 Impact factor: 3.558
FIGURE 1A conceptual schematic of behavioral/cognitive processes that contribute to the control of impulsive action. These are organized into reward “drive” and inhibitory “brake” processes.
Effects of serotonin receptors on reward-related and impulsive action behavior from preclinical pharmacology and genetic mouse models.
| Receptor | Behavioral effects | Reward | Behavioral inhibition: impulsive action |
| 5-HT1A | Modulates anxiety, depression, and the antidepressant response to SSRIs | Activation enhances sensitivity to reward | Agonists increase impulsive action likely through inhibition of raphe/serotonin signaling |
| 5-HT1B | Influences impulsive aggression and modulates social and drug reward | Activation reduces incentive motivation and knockout increases reward motivation | Knockout increases impulsive action |
| 5-HT2A | Pro-hallucinogenic, necessary for psychedelic effects | Activation decreases incentive motivation | Activation increases impulsive action, antagonists reduce impulsivity |
| 5-HT2B | Impulsivity, cognition, and anxiety | Knockout/blockade reduces reward sensitivity, and activation is required for some rewarding effects | Knockout increases impulsivity |
| 5-HT2C | Influences feeding, stress, and sex behavior | Activation reduces incentive motivation | Activation decreases impulsive action |
| 5-HT3 | Nausea | Limited direct effects, but is necessary for the rewarding effects of MDMA, cocaine, morphine, and ethanol | No established effects |
| 5-HT4 | Anxiety, depression, and feeding | No effect | No established effects |
| 5-HT5 | Memory and depression | No established effects | No established effects |
| 5-HT6 | Memory, activity, and anxiety | Limited direct effects | No effect |
| 5-HT7 | Depression and anxiety | No established effects | No established effects |
Blue and orange shading represent directionality (decreased or increased, respectively) of receptor activation effects on reward-related behaviors and impulsive action.
FIGURE 2A simplified schematic of rodent Dorsal Raphé serotonergic efferents to brain regions implicated in reward (A) or behavioral inhibition (B). ACC, anterior cingulate cortex; BLA, basolateral amygdala; DRN, dorsal raphé nucleus; DS, dorsal striatum; HPC, hippocampus; LH, lateral hypothalamus; mPFC, medial prefrontal cortex; NAc, nucleus accumbens; OFC, orbitofrontal cortex; STN, subthalamic nucleus; SN, substantia Nigra; VP, ventral pallidum; VTA, ventral tegmental area.
FIGURE 3Hypothesized contribution of reward value and behavioral inhibition factors to commonly used preclinical behavioral assays is shown based on the location of measures on the reward and inhibition axes. Parameters extracted from commonly used assays of impulsive action, including Go/No-go (GNG), 5 choice serial reaction time task (5CSRTT), and differential reinforcement of low-rate responding (DRL) are included, as well as other operant tasks which measure motivation, e.g., progressive ratio (PR) and hedonic responses (sucrose preference and taste reactivity). Fear learning and rate of extinction of fear learning are also included as measures with low information about reward value. Highlighted with a “?” is an information space that would provide measures of impulsivity independent of reward, and has limited preclinical behavioral assays.